E-LIB Suche - Ergebnisse für: Weisel, K

1

Increased incidence of immune thrombocytopenia (ITP) in 202..:

Schaefers, C. ; Paulsen, F.‐O. ; Frenzel, C....
British Journal of Haematology. 201 (2023) 2 - p. 222-226 , 2023

Link: https://doi.org/10.1111/..

2

P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INE..:

Facon, T. ; Plesner, T. ; Usmani, S....
HemaSphere. 7 (2023) S2 - p. 18-19 , 2023

Link: https://doi.org/10.1097/..

3

P18 Adjusted Comparison of Teclistamab Versus Real-World Ph..:

Mateos, M.V. ; Chari, A. ; Usmani, S.Z....
Value in Health. 26 (2023) 12 - p. S5 , 2023

Link: https://doi.org/10.1016/..

4

P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D-RD) ..:

Weisel, K. ; Kumar, S. ; Moreau, P....
HemaSphere. 7 (2023) S2 - p. 14-15 , 2023

Link: https://doi.org/10.1097/..

5

P960: HEALTH-RELATED QUALITY OF LIFE IN THE LOCOMMOTION STU..:

Delforge, M. ; Moreau, P. ; Einsele, H....
HemaSphere. 6 (2022) - p. 850-851 , 2022

Link: https://doi.org/10.1097/..

6

P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN ..:

Suvannasankha, A. ; Bahlis, N. ; Trudel, S....
HemaSphere. 6 (2022) - p. 830-831 , 2022

Link: https://doi.org/10.1097/..

7

S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF ..:

van de Donk, N. W. ; Bahlis, N. ; Mateos, M.-V....
HemaSphere. 6 (2022) - p. 84-85 , 2022

Link: https://doi.org/10.1097/..

8

B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUM..:

Rodriguez-Otero, P ; Dholaria, B ; Askari, E...
HemaSphere. 6 (2022) - p. 7-8 , 2022

Link: https://doi.org/10.1097/..

9

P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS ..:

Usmani, S. Z. ; Mielnik, M. ; Koh, Y....
HemaSphere. 6 (2022) - p. 832-833 , 2022

Link: https://doi.org/10.1097/..

10

P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CEL..:

Einsele, H ; Cohen, AD ; Delforge, M...
HemaSphere. 6 (2022) - p. 15-15 , 2022

Link: https://doi.org/10.1097/..

11

OP24 Clinical efficacy and safety of guselkumab maintenance..:

Danese, S ; Panaccione, R ; Rubin, D T...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i026-i027 , 2022

Link: https://doi.org/10.1093/..

12

P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM..:

Weisel, K. ; Mateos, M.-V. ; Vincent, L....
HemaSphere. 6 (2022) - p. 861-862 , 2022

Link: https://doi.org/10.1097/..

13

P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TE..:

Einsele, H. ; Moreau, P. ; Delforge, M....
HemaSphere. 6 (2022) - p. 825-826 , 2022

Link: https://doi.org/10.1097/..

14

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY ..:

Hillengass, J. ; Cohen, A. D. ; Delforge, M....
HemaSphere. 6 (2022) - p. 849-850 , 2022

Link: https://doi.org/10.1097/..

15

P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN REL..:

Spencer, A. ; Moreau, P. ; Mateos, M.-V....
HemaSphere. 6 (2022) - p. 823-824 , 2022

Link: https://doi.org/10.1097/..